Sign in

CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471144582
Phone
781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,050,832
in 7 filings, $404K under 10b5-1 plans

Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 79 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-05 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +7,639 7,639
2024-06-05 Smith Julie Director Grant or award · Director Stock Option (Right to Buy) +7,639 7,639
2024-06-05 SMITH IAN F Director Grant or award · Director Stock Option (Right to Buy) +7,639 7,639
2024-06-05 Menzel Garry E Director Grant or award · Director Stock Option (Right to Buy) +7,639 7,639
2024-06-05 TZIANABOS ARTHUR Director Grant or award · Director Stock Option (Right to Buy) +7,639 7,639
2024-06-05 LEVIN ARTHUR A Director Grant or award · Director Stock Option (Right to Buy) +7,639 7,639
2024-06-05 Krainer Adrian R. Director Grant or award · Director Stock Option (Right to Buy) +7,639 7,639
2024-06-03 Ticho Barry CHIEF MEDICAL OFFICER Option exercise 10b5-1 +10,000 $0.60 $6K 12,485
2024-06-03 Ticho Barry CHIEF MEDICAL OFFICER Sale 10b5-1 −9,897 $15.21 $151K 2,588
2024-06-03 Ticho Barry CHIEF MEDICAL OFFICER Sale 10b5-1 −103 $15.78 $2K 2,485
2024-06-03 Ticho Barry CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 60,000
2024-05-20 Nash Huw M. COO & CBO Option exercise 10b5-1 +50,000 $0.40 $20K 50,000
2024-05-20 Nash Huw M. COO & CBO Sale 10b5-1 −50,000 $15.39 $770K 0
2024-05-20 Nash Huw M. COO & CBO Option exercise · Stock Option (Right to Buy) 10b5-1 −50,000 46,000
2024-05-20 Kaye Edward M. MD CEO Sale 10b5-1 −39,686 $15.39 $611K 29,664
2024-05-20 Kaye Edward M. MD CEO Sale 10b5-1 −2,664 $16.05 $43K 27,000
2024-05-20 Allan Jonathan GENERAL COUNSEL & CORP SEC Option exercise 10b5-1 +8,599 $7.07 $61K 11,197
2024-05-20 Allan Jonathan GENERAL COUNSEL & CORP SEC Sale 10b5-1 −8,599 $15.04 $129K 2,598
2024-05-20 Allan Jonathan GENERAL COUNSEL & CORP SEC Option exercise · Stock Option (Right to Buy) 10b5-1 −8,599 25,801
2024-05-15 Leggett Thomas Chief Financial Officer Grant or award · Stock Option (Right to Buy) +396,200 396,200

Page 16 of 24 · 461 trades